BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 6769111)

  • 21. [Comparison of laboratory and clinical antitubercular agent sensitivity tests].
    Popovic J; Praso R; Stosic Z; Davidovic C
    Plucne Bolesti Tuberk; 1971; 23(4):333-8. PubMed ID: 5004987
    [No Abstract]   [Full Text] [Related]  

  • 22. [Organization and methods of correcting the chemotherapy of destructive pulmonary tuberculosis].
    Kovalenko NI; Ginzburg TS; Shapovalov VP; Taranenko MI
    Probl Tuberk; 1987; (9):35-8. PubMed ID: 3422965
    [No Abstract]   [Full Text] [Related]  

  • 23. [Drug resistance of Mycobacterium tuberculosis and its significance in the hospital practice].
    Rudoĭ NM
    Probl Tuberk; 1996; (3):6-8. PubMed ID: 8754863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Considerations on drug-resistent tuberculosis patients admitted to G. Saint-Bois Hospital during the years 1966 to 1970].
    Piñeyro JA; Bazerque E; Fossemalle JR; Tarallo NH
    Hoja Tisiol; 1971; 28(1-2):77-88. PubMed ID: 5006266
    [No Abstract]   [Full Text] [Related]  

  • 25. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria].
    Fomicheva NI; Terentieva AS
    Probl Tuberk; 1981 Dec; (12):23-6. PubMed ID: 6801645
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bacteriostatic activity of the blood during treatment with chemotherapeutic agents and its clinical significance].
    Klebanov MA; Bibik NF
    Probl Tuberk; 1966; 44(12):48-53. PubMed ID: 4974818
    [No Abstract]   [Full Text] [Related]  

  • 27. [Several current problems in chemotherapy of tuberculosis].
    Moisescu V
    Ftiziologia; 1973; 22(3):225-37. PubMed ID: 4197127
    [No Abstract]   [Full Text] [Related]  

  • 28. [Bacteriostatic activity of the blood in pulmonary tuberculosis and its clinical significance].
    Alekseenko AM
    Probl Tuberk; 1979 Jan; (1):33-7. PubMed ID: 105352
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical research: course of pulmonary tuberculosis caused by polyresistant Mycobacterium tuberculosis].
    Daddi G; Lucchesi M; Mancini P; Matzeu M; Rossi P
    Ann Ist Carlo Forlanini; 1969; 29(4):330-8. PubMed ID: 5004331
    [No Abstract]   [Full Text] [Related]  

  • 30. [Resistance to antitubercular agents in patients with pulmonary tuberculosis treated in the period from 1967 to 1970].
    Marsenić B; Panajotović H
    Plucne Bolesti Tuberk; 1974; 26 Suppl 2():60-7. PubMed ID: 4216923
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of bronchial lesions in pulmonary tuberculosis with primary drug resistance of Mycobacteria].
    Fedotova ZN; Shesterina MV
    Probl Tuberk; 1978 Aug; (8):31-4. PubMed ID: 100778
    [No Abstract]   [Full Text] [Related]  

  • 32. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
    Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
    Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Terminal causes of death in patients suffering from pulmonary tuberculosis in relation to the drug sensitivity of the strains of Mycobacterium tuberculosis].
    Daddi G; Lucchesi M; Mancini P; Rossi P; Sbampato M; Storniello G
    Ann Ist Carlo Forlanini; 1969; 29(4):339-48. PubMed ID: 5004332
    [No Abstract]   [Full Text] [Related]  

  • 34. [Secondary drug resistance of Mycobacterium tuberculosis in coniotuberculosis and pulmonary tuberculosis].
    Beskrovnyĭ PS; Varenko IuS; Revenko TA; Khokhlov VN
    Probl Tuberk; 1976 Jul; (7):66-70. PubMed ID: 822417
    [No Abstract]   [Full Text] [Related]  

  • 35. [Importance of microbiological research in correcting the antibacterial therapy of tuberculosis].
    Dolzhanskiĭ VM; Sagalovich VIa
    Ter Arkh; 1987; 59(7):77-80. PubMed ID: 3118492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Isolation of atypical Mycobacteria from the patients with tuberculosis and methods of their primary identification].
    Mikhaĭlova LV
    Sov Zdravookhr Kirg; 1973; 4():53-5. PubMed ID: 4207845
    [No Abstract]   [Full Text] [Related]  

  • 37. [Primary mycobacterial resistance and its relations to the clinical aspects and therapy of tuberculosis].
    Nitti V
    Arch Tisiol Mal Appar Respir; 1967 Jun; 22(6):519-34. PubMed ID: 4973216
    [No Abstract]   [Full Text] [Related]  

  • 38. [Evaluation of secondary chemoresistance of Koch bacillus at the present time].
    Jemna I; Lego I
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(4):243-4. PubMed ID: 6278569
    [No Abstract]   [Full Text] [Related]  

  • 39. [Incidence of primary and secondary resistance of M. tuberculosis in East Germany in 1983 in hospitalized patients].
    Kalich R; Käppler W
    Z Erkr Atmungsorgane; 1986; 167(3):254-60. PubMed ID: 3105189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-resistant tuberculosis: resistance mechanisms and rapid susceptibility testing.
    Pfyffer GE
    Schweiz Med Wochenschr; 2000 Dec; 130(49):1909-13. PubMed ID: 11153397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.